(Q33960291)
Statements
1 reference
Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). (English)
1 reference
Michael Nauck
1 reference
Ruth S Weinstock
1 reference
Guillermo E Umpierrez
1 reference
Bruno Guerci
1 reference
Zachary Skrivanek
1 reference
Zvonko Milicevic
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference